In the latest trading session,, 19.68 million Vivos Therapeutics Inc (NASDAQ:VVOS) shares changed hands as the company’s beta touched 6.97. With the company’s most recent per share price at $3.77 changing hands around $0.61 or 19.30% at last look, the market valuation stands at $22.20M. VVOS’s current price is a discount, trading about -66.58% off its 52-week high of $6.28. The share price had its 52-week low at $1.97, which suggests the last value was 47.75% up since then. When we look at Vivos Therapeutics Inc’s average trading volume, we note the 10-day average is 0.35 million shares, with the 3-month average coming to 148.30K.
Vivos Therapeutics Inc (NASDAQ:VVOS) trade information
Instantly VVOS is in green as seen in intraday trades today. With action 26.94%, the performance over the past five days has been green. The company’s shares are showing year-to-date upside of 57.74%, with the 5-day performance at 26.94% in the green. However, in the 30-day time frame, Vivos Therapeutics Inc (NASDAQ:VVOS) is 55.79% up. Looking at the short shares, we see there were 0.31 million shares sold at short interest cover period of 2.16 days.
The consensus price target for the stock as assigned by Wall Street analysts is 2.25, meaning bulls need a downside of -67.56% from its recent market value. According to analyst projections, VVOS’s forecast low is 2.25 with 2.25 as the target high. To hit the forecast high, the stock’s price needs a 40.32% surge from its current level, while the stock would need to tank 40.32% for it to hit the projected low.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 32.77%. The 2025 estimates are for Vivos Therapeutics Inc earnings to increase by 36.04%.
VVOS Dividends
Vivos Therapeutics Inc is expected to release its next quarterly earnings report on 2025-May-15.
Vivos Therapeutics Inc (NASDAQ:VVOS)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 24.48% of Vivos Therapeutics Inc shares while 9.25% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 12.24%. There are 9.25% institutions holding the Vivos Therapeutics Inc stock share, with STRATEGIC WEALTH INVESTMENT GROUP, LLC the top institutional holder. As of 2024-06-30, the company held 3.9893% of the shares, roughly 0.13 million VVOS shares worth $0.3 million.
GEODE CAPITAL MANAGEMENT, LLC holds the second largest percentage of outstanding shares, with 0.6409% or 20691.0 shares worth $45933.0 as of 2024-06-30.
Among Mutual Funds, the top two as of Mar 31, 2025 were VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund and Fidelity Concord Street Trust-Fidelity Extended Market Index Fund . With 42.63 shares estimated at $0.17 million under it, the former controlled 0.72% of total outstanding shares. On the other hand, Fidelity Concord Street Trust-Fidelity Extended Market Index Fund held about 0.56% of the shares, roughly 32.85 shares worth around $0.13 million.
